Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

The Zacks Analyst Blog Highlights: Morris, EOG Resources, Becton, Dickinson, Sirius XM And ABB

Published 12/13/2017, 10:39 PM
Updated 07/09/2023, 06:31 AM

For Immediate Release

Chicago, IL – December 14, 2017 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Morris (NYSE:PM) , EOG Resources (NYSE:EOG) , Becton, Dickinson (NYSE:BDX) , Sirius XM (NASDAQ:SIRI) and ABB (NYSE:ABB) .

Here are highlights from Wednesday’s Analyst Blog:

Top Research Reports for Phillip Morris, EOG Resources and Becton, Dickinson

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Phillip Morris (PM), EOG Resources (EOG) and Becton, Dickinson (BDX). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.

Phillip Morris’s shares have underperformed the Zacks Tobacco industry over the last three months (-8.1% vs. +3%). But the Zacks analyst likes Philip Morris’ consistent efforts to improve the performance of its low risk products. In this category, the company’s IQOS smokeless cigarette have been steadily expanding owing to consumer demand.

Higher cigarette pricing has also been favoring the company. Though the company has been benefiting from enhanced volumes and revenues in the reduced risk products category, it has been suffering majorly due to consistent declines in cigarette volumes stemming from the shift of customer preference away from tobacco products.

Owing to such headwinds, Phillip Morris continued with its drab performance in third-quarter 2017, wherein both earnings and revenues lagged the Zacks Consensus Estimate. These factors also compelled management to lower its 2017 view.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Shares of EOG Resources have gained around +12.7% over the last six months, outperforming the Zacks Oil & Gas E&P Industry, which has gained +4% over the same period. EOG Resources holds premium acreages in the Permian, Bakken and Eagle Ford oil shale plays in the United States.

The Zacks analyst likes the firm’s plan to complete 505 wells in the area, significantly higher than 443 recorded in 2016. The firm expects 80% and 90% of the wells to meet the standards of premium wells in 2017 and 2018, respectively. In the promising U.S. shale plays, EOG Resources has identified 7,200 premium wells that can give access to almost 6.5 billion barrels of oil equivalent estimated potential reserves over a period of 10 years.

However, the company’s lack of exposure to international resources is a drag. On top of that, increasing debt load is a cause of concern. Moreover, cash balances have been declining substantially over the first nine months, reflecting balance sheet weakness.

Becton, Dickinson’s shares have outperformed the Zacks Dental Supplies industry over the last one year, gaining +30.5% vs. +19.1%. Becton, Dickinson and Company, popularly known as BD, is steadily progressing with its planned acquisition of medical technology player, C. R. Bard. Post-completion, BD expects growth in adjusted earnings starting fiscal 2019. The Zacks analyst thinks the acquisition is a strategic one which will generate benefits from complementary businesses and geographical expansion.

Further, BD announced that it will divest its soft tissue core needle biopsy products for $100 million to Merit Medical. On the flipside, lackluster performance by the Medical segment is a concern.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Performance in the segment was affected by sluggishness in the Medication Management Solutions and Pharmaceutical Systems units in the United States. BD temporarily paused shipments of its insulin infusion sets. The voluntary recall of Barricor blood collection tubes in the recent past also adds to BD’s woes.

Other noteworthy reports we are featuring today include Sirius XM (SIRI) and ABB (ABB).

Will You Make a Fortune on the Shift to Electric Cars?

Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>

Join us on Facebook (NASDAQ:FB): http://www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553657748?ref=ts

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Media Contact

Zacks Investment Research

800-767-3771 ext. 9339

support@zacks.com

http://www.zacks.com

Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit http://www.zacks.com/performancefor information about the performance numbers displayed in this press release.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .


Sirius XM Holdings Inc. (SIRI): Free Stock Analysis Report

ABB Ltd (ABB): Free Stock Analysis Report

Becton, Dickinson and Company (BDX): Free Stock Analysis Report

EOG Resources, Inc. (EOG): Free Stock Analysis Report

Philip Morris International Inc (PM): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.